NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Onegene Biotechnology

Onegene Biotechnology

Private
South KoreaHealthcare & Life Scienceshttps://onegenebt.com/

Last Round

Series B

May 1, 2022

Total Funding Raised

$48.08M

Company Overview

Onegene Biotechnology is a biotechnology company that develops multi-target therapeutic drugs for the treatment of cancer, metabolic, and inflammatory diseases using its proprietary protein conjugation platform technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyprotein therapeuticsmulti-specific proteinsdrug discoveryprotein engineeringbiologicsimmuno-oncologymetabolic diseaseprotein conjugationrecombinant proteinsNASHfibrosispreclinical researchbiotech platformdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Onegene Biotechnology Comparables

Compare Onegene Biotechnology with similar companies based on industry and business-model similarity.

Onegene Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VALANX Biotech
79%
ProAbTech Co., Ltd.
79%
ABL Bio, Inc.
75%

Onegene Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 1, 2022
Series AFeb 18, 2021
Pre SeedAug 1, 2020
AcceleratorSep 1, 2019

Key People

Founding team and executive leadership

Sungjin Park

CEO

Executive Team

Josh H. Hwang

CFO & COO 부사장

Executive Team

Onegene Biotechnology Investors

Notable investors and investment history

Onegene Biotechnology investors
InvestorRounds
BNH INVESTMENTSeries A, Series B
Shinhan Venture InvestmentSeries B
Bluepoint PartnersAccelerator
UTC InvestmentSeries A, Series B
Premier PartnersSeries A, Series B
Timefolio Asset ManagementSeries B
Korea Investment & Securities Co., Ltd.Series B

Onegene Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Onegene Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Onegene Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea
Employee Range21
Year Founded2016
Last FundingMay 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.